Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Wenzel

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2004
The design of clinical trials that evaluate antifungal prophylaxis and combination therapy: introduction and overviewJohn H Rex, John R Wingard, Richard Wenzel, et al.
Cephalalgia : an International Journal of Headache|May 28, 2022
Long-term open-label safety study of galcanezumab in patients with episodic or chronic cluster headacheRobert Riesenberg, Charly Gaul, Chad E Stroud, et al.
Headache|November 12, 2020
Treatment Outcomes in Patients Treated With Galcanezumab vs Placebo: Post Hoc Analyses From a Phase 3 Randomized Study in Patients With Episodic Cluster HeadacheDavid Kudrow, J Scott Andrews, Mallikarjuna Rettiganti, et al.
Journal of Pain Research|July 16, 2021
Impact of Galcanezumab on Total Pain Burden: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Episodic Cluster HeadacheJ Scott Andrews, David Kudrow, Mallikarjuna Rettiganti, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 28, 2020
No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19Kenneth Sands, Richard Wenzel, Laura McLean, et al.
Headache|November 22, 2021
Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatmentMiguel J A Láinez, Jean Schoenen, Chad Stroud, et al.
Headache|April 1, 2022
Challenges and complexities in designing cluster headache prevention clinical trials: A narrative reviewDavid W Dodick, Peter J Goadsby, Messoud Ashina, et al.
Infection Control and Hospital Epidemiology|November 23, 2019
The learning hospital: From theory to practice in a hospital infection prevention programOlivia C R Hess, Meha Srivastava, Rachel Pryor, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2004
The design of clinical trials that evaluate antifungal prophylaxis and combination therapy: introduction and overviewJohn H Rex, John R Wingard, Richard Wenzel, et al.
Cephalalgia : an International Journal of Headache|May 28, 2022
Long-term open-label safety study of galcanezumab in patients with episodic or chronic cluster headacheRobert Riesenberg, Charly Gaul, Chad E Stroud, et al.
Headache|November 12, 2020
Treatment Outcomes in Patients Treated With Galcanezumab vs Placebo: Post Hoc Analyses From a Phase 3 Randomized Study in Patients With Episodic Cluster HeadacheDavid Kudrow, J Scott Andrews, Mallikarjuna Rettiganti, et al.
Journal of Pain Research|July 16, 2021
Impact of Galcanezumab on Total Pain Burden: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Episodic Cluster HeadacheJ Scott Andrews, David Kudrow, Mallikarjuna Rettiganti, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 28, 2020
No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19Kenneth Sands, Richard Wenzel, Laura McLean, et al.
Headache|November 22, 2021
Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatmentMiguel J A Láinez, Jean Schoenen, Chad Stroud, et al.
Headache|April 1, 2022
Challenges and complexities in designing cluster headache prevention clinical trials: A narrative reviewDavid W Dodick, Peter J Goadsby, Messoud Ashina, et al.
Infection Control and Hospital Epidemiology|November 23, 2019
The learning hospital: From theory to practice in a hospital infection prevention programOlivia C R Hess, Meha Srivastava, Rachel Pryor, et al.
Pageof 3